UW21074
OPEN TO ACCRUAL
Phase 1 of TJ033721 in Advanced or Metastatic Solid Tumors
UW22072
OPEN TO ACCRUAL
PH 1 Study CUE-102 in Subjects with HLA-A*0201 with WT1 Positive Recurrent/Metastatic Cancers
UW23064
OPEN TO ACCRUAL
PH1 Study of EO-3021, an Anti-claudin 18.2, in patients with Solid Tumors Likely to Express CLDN18.2